within Pharmacolibrary.Drugs.ATC.M;

model M01AH03
  extends Pharmacokinetic.Models.PK_2C_enteral(
    weight         = 70,
    F              = 0.83,
    Cl             = 0.0001,
    adminDuration  = 600,
    adminMass      = 40 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.055,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.037333333333333336,
    Tlag           = 10.200000000000001,            
    Vdp             = 0.014,
    k12             = 22,
    k21             = 22
    
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>M01AH03</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Valdecoxib is a selective cyclooxygenase-2 (COX-2) inhibitor used as a nonsteroidal anti-inflammatory drug (NSAID) for the treatment of osteoarthritis, rheumatoid arthritis, and menstrual pain. It was withdrawn from the market due to concerns about increased cardiovascular risk.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters in healthy adult individuals after oral administration.</p><h4>References</h4><ol><li><p>Ormrod, D, et al., &amp; Wagstaff, AJ (2002). Valdecoxib. <i>Drugs</i> 62(14) 2059–2073. DOI:<a href=\"https://doi.org/10.2165/00003495-200262140-00005\">10.2165/00003495-200262140-00005</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/12269850/\">https://pubmed.ncbi.nlm.nih.gov/12269850</a></p></li><li><p>Hu, J, et al., &amp; Chen, XP (2020). Effects of Dexmedetomidine on the Pharmacokinetics of Parecoxib and Its Metabolite Valdecoxib in Beagles by UPLC-MS/MS. <i>BioMed research international</i> 2020 1563874–None. DOI:<a href=\"https://doi.org/10.1155/2020/1563874\">10.1155/2020/1563874</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/32832543/\">https://pubmed.ncbi.nlm.nih.gov/32832543</a></p></li><li><p>Zhang, JY, et al., &amp; Breau, AP (2003). Pharmacokinetics and metabolism of a COX-2 inhibitor, valdecoxib, in mice. <i>Drug metabolism and disposition: the biological fate of chemicals</i> 31(4) 491–501. DOI:<a href=\"https://doi.org/10.1124/dmd.31.4.491\">10.1124/dmd.31.4.491</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/12642477/\">https://pubmed.ncbi.nlm.nih.gov/12642477</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end M01AH03;
